Eltoukhy Helmy's Form 4 filing
Guardant Health, Inc. (GH) · filed Nov 23, 2021
- Accession no.
- 0001576280-21-000109
- Filed
- Nov 23, 2021
- Trade date
- Nov 19-23, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market purchases total $10.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eltoukhy HelmyCIK 0001752968 | Director, Officer (Co-Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | COMMON STOCK | PPurchaseAcquired | +37,591 | $97.90F1 | +$3,680,158.9 | 1,889,277 | Direct | |
| Nov 19, 2021 | COMMON STOCK | PPurchaseAcquired | +12,409 | $98.75F2 | +$1,225,388.75 | 1,901,686 | Direct | |
| Nov 23, 2021 | COMMON STOCK | PPurchaseAcquired | +3,106 | $92.23F3 | +$286,466.38 | 1,904,792 | Direct | |
| Nov 23, 2021 | COMMON STOCK | PPurchaseAcquired | +26,394 | $93.04F4 | +$2,455,697.76 | 1,931,186 | Direct | |
| Nov 23, 2021 | COMMON STOCK | PPurchaseAcquired | +5,000 | $94.00 | +$470,000 | 1,936,186 | Direct | |
| Nov 23, 2021 | COMMON STOCK | PPurchaseAcquired | +5,000 | $95.50 | +$477,500 | 1,941,186 | Direct | |
| Nov 23, 2021 | COMMON STOCK | PPurchaseAcquired | +14,900 | $96.83F5 | +$1,442,767 | 1,956,086 | Direct | |
| Nov 23, 2021 | COMMON STOCK | PPurchaseAcquired | +100 | $98.00 | +$9,800 | 1,956,186 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $97.445 to $98.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $98.71 to $98.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.88 to $92.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $92.88 to $93.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $96.50 to $97.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.